K. Waite

发表

Phytoestrogen exposure elevates PTEN levels.

C. Eng, K. Waite, Michelle R. Sinden, 2005, Human molecular genetics.

Oncogenic Ha-Ras Transformation Modulates the Transcription of the CTP:Phosphocholine Cytidylyltransferase α Gene via p42/44MAPK and Transcription Factor Sp3*

D. Vance, K. Waite, M. Bakovic, 2003, The Journal of Biological Chemistry.

Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein.

C. Eng, K. Waite, T. Minaguchi, 2006, Cancer research.

REVIEW ARTICLE Protean PTEN: Form and Function

C. Eng, K. Waite, 2002 .

Protean PTEN: form and function.

C. Eng, K. Waite, 2002, American journal of human genetics.

BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.

C. Eng, K. Waite, 2003, Human molecular genetics.

Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone

C. Chen, C. Eng, K. Waite, 2006, International journal of cancer.

Phosphatidic Acid-mediated Phosphorylation of the NADPH Oxidase Component p47-phox

K. Waite, L. Mcphail, R. Wallin, 1997, The Journal of Biological Chemistry.

PTEN regulates phospholipase D and phospholipase C.

C. Eng, K. Waite, C. Alvarez-Breckenridge, 2007, Human molecular genetics.

A Phosphatidic Acid-activated Protein Kinase and Conventional Protein Kinase C Isoforms Phosphorylate p22 phox , an NADPH Oxidase Component*

K. Waite, L. Mcphail, D. Regier, 1999, The Journal of Biological Chemistry.

Regulation of the PTEN promoter by statins and SREBP.

C. Eng, S. Planchon, K. Waite, 2007, Human molecular genetics.

Nuclear PTEN levels and G2 progression in melanoma cells

C. Eng, K. Waite, T. Romigh, 2009, Melanoma research.

A novel protein kinase target for the lipid second messenger phosphatidic acid.

K. Waite, L. Mcphail, S. Sergeant, 1999, Biochimica et biophysica acta.

Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase.

K. Waite, L. Mcphail, D. Qualliotine-Mann, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Phosphatidic Acid Regulates Tyrosine Phosphorylating Activity in Human Neutrophils

K. Waite, L. Mcphail, S. Sergeant, 2001, The Journal of Biological Chemistry.

PPARγ, PTEN, and the Fight against Cancer

K. Waite, Rosemary E. Teresi, 2008, PPAR research.

The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.

Michael C. Ostrowski, C. Eng, M. Ostrowski, 2006, Human molecular genetics.

Enhanced Expression and Activation of CTP:Phosphocholine Cytidylyltransferase β2 during Neurite Outgrowth*

R. Campenot, D. Vance, K. Waite, 2003, Journal of Biological Chemistry.

Choline deficiency-induced liver damage is reversible in Pemt(-/-) mice.

D. Vance, K. Waite, Nora R. Cabilio, 2002, The Journal of nutrition.

The nuclear affairs of PTEN

C. Eng, S. Planchon, K. Waite, 2008, Journal of Cell Science.

Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome.

C. Eng, K. Waite, M. Pezzolesi, 2007, Human molecular genetics.

From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family

C. Eng, K. Waite, 2003, Nature Reviews Genetics.

Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.

C. Plass, C. Morrison, C. Eng, 2005, The Journal of clinical endocrinology and metabolism.

Functional significance of Sp1, Sp2, and Sp3 transcription factors in regulation of the murine CTP:phosphocholine cytidylyltransferase alpha promoter.

D. Vance, K. Waite, M. Bakovic, 2000, Journal of lipid research.

Transcriptional activation of the murine CTP:phosphocholine cytidylyltransferase gene (Ctpct): combined action of upstream stimulatory and inhibitory cis-acting elements.

D. Vance, K. Waite, M. Bakovic, 1999, Biochimica et biophysica acta.

ATP modulates PTEN subcellular localization in multiple cancer cell lines

C. Eng, J. Houghton, S. Planchon, 2008, Human molecular genetics.

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

J. Ivanovich, C. Eng, G. Feldman, 2003, American journal of human genetics.

Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function

C. Eng, S. Planchon, K. Waite, 2009, Human molecular genetics.

Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.

Charis Eng, Kristin A Waite, P. Platzer, 2008, American journal of human genetics.

Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.

P. Platzer, C. Eng, K. Waite, 2008, American journal of human genetics.

Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.

C. Eng, K. Waite, M. Pezzolesi, 2007, American journal of human genetics.

From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family.

C. Eng, K. Waite, 2003, Nature reviews. Genetics.

Dimethylethanolamine does not prevent liver failure in phosphatidylethanolamine N-methyltransferase-deficient mice fed a choline-deficient diet.

D. Vance, K. Waite, 2004, Biochimica et biophysica acta.

Why Expression of PhosphatidylethanolamineN-Methyltransferase Does Not Rescue Chinese Hamster Ovary Cells That Have an Impaired CDP-Choline Pathway*

D. Vance, K. Waite, 2000, The Journal of Biological Chemistry.

No PTEN protein and altered downstream signaling due to heterozygous germline PTEN mutations in Cowden syndrome

S. Lemeshow, C. Eng, K. Waite, 2003 .

Choline Deﬁciency–Induced Liver Damage Is Reversible in Pemt / Mice 1

D. Vance, K. Waite, Nora R. Cabilio, 2001 .